Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-126.35%
operating margin TTM
-91.36%
revenue TTM
937.97 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -3.61 |
| peg ratio | -0.18 |
| price to book ratio | -1.82 |
| price to sales ratio | 4.92 |
| enterprise value multiple | -20.15 |
| price fair value | -1.82 |
profitability ratios | |
|---|---|
| gross profit margin | 87.09% |
| operating profit margin | -91.36% |
| pretax profit margin | -126.35% |
| net profit margin | -126.35% |
| return on assets | -85.37% |
| return on equity | 55.14% |
| return on capital employed | -125.87% |
liquidity ratios | |
|---|---|
| current ratio | 1.73 |
| quick ratio | 1.69 |
| cash ratio | 0.98 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 89.12 |
| operating cycle | 251.97 |
| days of payables outstanding | 80.48 |
| cash conversion cycle | 171.49 |
| receivables turnover | 2.24 |
| payables turnover | 4.54 |
| inventory turnover | 4.10 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | -0.01 |
| long term debt to capitalization | -0.00 |
| total debt to capitalization | -0.01 |
| interest coverage | -0.93 |
| cash flow to debt ratio | -61.47 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.29 |
| cash per share | 1.78 |
| operating cash flow per share | -2.29 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -61.47 |
| short term coverage ratios | -257.37 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) reported earnings?
Phathom Pharmaceuticals, Inc. (PHAT) published its most recent earnings results on 30-10-2025.
What is Phathom Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)'s trailing twelve months ROE is 55.14%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Phathom Pharmaceuticals, Inc. (PHAT) currently has a ROA of -85.37%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PHAT's net profit margin stand at?
PHAT reported a profit margin of -126.35% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PHAT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.73 in the most recent quarter. The quick ratio stood at 1.69, with a Debt/Eq ratio of -0.01.